Streetbeat News

Stock Prices

SIRI

Evercore ISI Group analyst Vijay Jayant has downgraded Sirius XM Holdings (NASDAQ:SIRI) from In-Line to Underperform and set a price target of $4.5.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:29 am

SIRI

Pivotal Research analyst Jeffrey Wlodarczak has downgraded Sirius XM Holdings (NASDAQ:SIRI) from Hold to Sell, while raising the price target from $4 to $4.5.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:27 am

AN

AXP

CSX

ISRG

SLB

American Express (AXP), Intuitive Surgical (ISRG), Schlumberger (SLB), CSX Corporation (CSX), and AutoNation (AN) are the stocks to watch heading into Friday. AXP is expected to post quarterly earnings of $2.81 per share on revenue of $15.48 billion. ISRG reported better-than-expected earnings for Q2. SLB is expected to have earned 71 cents per share on revenue of $8.22 billion. CSX reported in-line earnings for Q2, but sales missed expectations. AN is expected to report quarterly earnings of $5.90 per share on revenue of $6.74 billion.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 9:09 am

TSLA

Tesla's stock fell nearly 10% despite a strong quarterly report, with Future Fund's Gary Black suggesting that CEO Elon Musk's focus on autonomy over existing successful businesses may have contributed to the drop. Black argued that if Musk had highlighted the company's dominance in the EV market and its tripling energy profits, the stock might have performed better. He also criticized Musk's hinting at potential future price cuts, suggesting it could discourage immediate purchases.

Portfolio Pulse from Shanthi Rexaline

July 21, 2023 | 9:07 am

XPEV

JP Morgan analyst Nick Lai has downgraded XPeng (NYSE:XPEV) from Neutral to Underweight and raised the price target from $7.5 to $10.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 8:48 am

EBS

The FDA has approved Emergent BioSolutions' two-dose anthrax vaccine for adults, leading to a rise in the company's stock.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 8:39 am

KPRX

Kiora Pharmaceuticals has received a deficiency letter from NASDAQ, indicating that the company is not in compliance with NASDAQ's listing rules. The company has until January 15, 2024, to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 8:20 am

AN

AutoNation, Inc. (NYSE:AN) is expected to report lower Q2 earnings at $5.90 per share, down from $6.48 per share a year ago. The company's revenue is projected to be $6.74 billion. AutoNation shares fell 2.5% to close at $176.92 on Thursday. Recent price target changes by analysts show mixed views, with some seeing upside potential and others predicting a downside.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 8:19 am

AN

AXP

JNJ

NFLX

SLB

TRV

TSLA

Investor sentiment in the US declined as the Nasdaq fell by 2.05% due to a drop in Netflix and Tesla shares. The Dow Jones, however, recorded gains for a ninth straight session, boosted by strong earnings from Johnson & Johnson and The Travelers Companies. Investors are now awaiting earnings results from American Express, Schlumberger, and AutoNation. The CNN Money Fear and Greed index, a measure of market sentiment, remained in the 'Extreme Greed' zone.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 7:20 am

EWA

Australia's S&P/ASX 200 index closed 0.15% lower at 7,313.90, with the technology sector being the worst performer due to disappointing results from Wall Street’s tech giants. The AUD/USD was up 0.09% to 0.6785.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 6:58 am